Detalhe da pesquisa
1.
Serum Metabolomics Investigation of Humanized Mouse Model of Dengue Virus Infection.
J Virol
; 91(14)2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28468882
2.
Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.
Blood
; 128(10): 1396-407, 2016 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338099
3.
Human natural killer cells control Plasmodium falciparum infection by eliminating infected red blood cells.
Proc Natl Acad Sci U S A
; 111(4): 1479-84, 2014 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24474774
4.
Induction of functional human macrophages from bone marrow promonocytes by M-CSF in humanized mice.
J Immunol
; 191(6): 3192-9, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23935193
5.
CD166(pos) subpopulation from differentiated human ES and iPS cells support repair of acute lung injury.
Mol Ther
; 20(12): 2335-46, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22968480
6.
Successive Immunization With Epitope-Decreasing Dengue Antigens Induced Conservative Anti-Dengue Immune Responses.
Front Immunol
; 11: 585133, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33101316
7.
Sequential immunization induces strong and broad immunity against all four dengue virus serotypes.
NPJ Vaccines
; 5(1): 68, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728482
8.
Microfluidic label-free bioprocessing of human reticulocytes from erythroid culture.
Lab Chip
; 20(18): 3445-3460, 2020 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32793940
9.
Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice.
Front Immunol
; 10: 1429, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31281322
10.
Erratum: Author Correction: Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.
NPJ Vaccines
; 4: 46, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31666992
11.
Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.
NPJ Vaccines
; 4: 27, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285858